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Study objectives: To evaluate the rapid urine antigen tests, including a new rapid
immunochromatographic test (ICT) for the detection of the Streptococcus
pneumoniae antigen and an enzyme immunoassay (EIA) for the detection of the
Legionella antigen, in order to improve the diagnosis of community-acquired
pneumonia (CAP) in adults.
Design: Prospective study.
Setting: A tertiary hospital in Spain.
Patients: We consecutively recruited 107 adults with CAP evaluated at our hospital.
Interventions: The analyses included blood and sputum cultures, pleural fluid
culture (if present) and serologic studies. The detection of the Legionella
pneumophila urinary antigen was performed by EIA, and the detection of S.
pneumoniae antigen in urine samples was performed by counterimmunoelectrophor-
esis (CIE) and a rapid ICT.
Results: Using conventional microbiologic tests we succeeded in performing the
etiologic diagnosis of 39 out of the 107 cases (36.4%). The inclusion of rapid antigen
detection techniques increased the percentage of diagnosis to 54.2%, which
represents a total increase of 17.8% ðP ¼ 0:034Þ.
Conclusions: The data obtained in this study indicate that rapid urine antigen tests
are very useful to determine CAP etiology in adults and, consequently, to quickly
identify a group of patients in whom narrow spectrum antibiotics may be used.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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In etiological studies of community-acquired pneu-
monia (CAP) there is a large number of patients
(between 30% and 70%, usually more than 50%) in
whom the responsible pathogen is not defined,
even when an extensive testing for diagnosis is
carried out.1–3 This may be caused by several
factors, such as the presence of uncommon patho-
gens; non-infective processes that simulate pneu-
monia; previous treatment with antibiotics that
may affect the sensitivity of some microbiological
techniques and, mainly, the limitation of standard
techniques for the identification of common patho-
gens due to a lack of sensitivity or the difficulty to
obtain good samples.
In most series,4,5 Streptococcus pneumoniae is
still the most common cause of CAP, but it is
undoubtedly underdiagnosed due to the limitations
of the standard tests used for diagnosis. Further-
more, S. pneumoniae may even cause pneumonia in
patients who have no pathogen identified using
routine diagnostic methods. In one study6 using
lung aspirates by trans-thoracic needle aspiration
obtained from hospitalized patients, it was found
that S. pneumoniae was the leading cause of
pneumonia of unknown etiology, which was de-
tected in about one-third of the cases when a cause
could not be determined using standard diag-
nostic tests. In other studies,4,5 Legionella was
found in up to 10% of all episodes in hospitalized
patients. Moreover, S. pneumoniae and Legionella
are among the most common organisms that cause
severe CAP in hospitalized patients requiring ICU
admission.
In an effort to improve the diagnosis of patients
with pneumonia, and taking into account that a
quick diagnosis is crucial for the management of
CAP, there has been a considerable interest in non-
invasive alternative techniques such as the detec-
tion of antigens in urine. In several studies,7–9 rapid
urine antigen detection seemed a promising test to
early detect S. pneumoniae and Legionella pneu-
mophila. Sensitivity of the tests could increase
if the antigen present in the urine is concentrated
by selective ultrafiltration. Using concentrated
urine (CU) the sensitivity of the Legionella urinary
antigen test increases without affecting specifi-
city.7 Furthermore, these tests may also accu-
rately determine the first choice antibiotic for CAP.
The aim of our study was to prospectively evaluate
the impact of these rapid urine antigen tests
using both CU and non-concentrated urine (NCU)
samples from adults with pneumonia admitted to
our hospital, in order to improve the etiology
diagnosis.Material and methods
Group of patients
Starting in February 2000 we prospectively studied,
over a period of 20 months, a number of con-
secutive adults aged 16 years and over, assessed
in the Pneumology Unit of a tertiary hospital
(Hospital Universitari Germans Trias i Pujol, Barce-
lona, Spain).
In a data collection form we analyzed the
epidemiology, the comorbidity of the disease, the
antibiotics taken prior to admission to hospital, the
days of symptom evolution, the clinical signs, the
analytical parameters, the radiological features
and the treatment with antibiotics.
Comorbidity was defined as the presence of any
of the following conditions for which the patient
was under active medical supervision or was
receiving treatment at the time of admission to
hospital: pulmonary disease (i.e., chronic obstruc-
tive pulmonary disease (COPD), chronic bronchitis,
bronchiectasies, asthma), ischemic heart disease,
cardiac failure, cerebrovascular diseases (including
previous transient ischemic attacks), neoplastic
conditions, immunosuppression, diabetes mellitus,
chronic renal or liver disease.
Inclusion criteria All patients had CAP, defined as the presence of
an illness lasting for at least 2 days. A chest radiograph performed at the time of
admission that showed a radiographic pulmonary
infiltrate that was at least segmental or present
in one lobe, consistent with pneumonia and not
pre-existing. Clinical features consistent with an acute lower
respiratory tract infection including two or more
of the following new or increasing cough, sputum
production, pleuritic chest pain, dyspnea, pul-
monary consolidation by physical examination;
one or more constitutional symptoms including
temperature 437.8 1C, sweating, altered men-
tal status, aches and pains, headaches, coryza or
sore throat. Pneumonia treated with antibiotics by the
attending physician.
Exclusion criteria
The exclusion criteria were the following: patients
hospitalized within the previous 15 days when
pneumonia was distal to the bronchial obstruction
(e.g., from lung cancer), patients with suspected
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plete follow-up for at least 4 weeks. Patients with
pneumonia caused by tuberculosis, or who had an
emerging alternative diagnosis (e.g., pulmonary
edema, pulmonary or septic emboli or malignancy),
or those who were immunocompromised due to:
leukopenia o1000/mm or neutropenia o500/mm
not attributable to pneumonia; HIV infection;
treatment with either chemotherapeutic agents
during the last 6 months prior to admission to
hospital or ciclosporine, azathioprine or predniso-
lone-equivalent (over 15mg/day), for at least 3
months prior to admission.Microbiological studies
We used standard methods for culturing and
identifying microorganisms isolated from blood
samples, respiratory samples and pleural fluid.
Blood samples were inoculated on aerobian and
anaerobian blood culture bottles, and incubated
for 5 days in the automatic blood culture analyzer
Bact/Alert (BioMe´rieux, Marcy L’Etoile. France).
For respiratory samples, Gram’s staining and a
standard bacteriological culture were done, includ-
ing selective means to isolate Legionella spp. For
culturing, only good quality sputum samples con-
taining 425 polymorphonuclear leukocytes and
o10 squamous epithelial cells  100 field were
accepted. Detection techniques were performed
with respiratory samples using the latex particle
agglutination technique for both S. pneumoniae
capsular antigen (slides pneumo-kit. BioMe´rieux.
Macy L’Etoile. France) and type-b Haemophilus
influenzae (Phadebacts Haemophilus Test Boule
Diagnostics AB. Huddinge, Sweden).
A serological study for the detection of specific
antibodies was carried out in paired serum samples
collected during the acute and the convalescent
phases 3–6 weeks later and was verified with
Mycoplasma pneumoniae for agglutination in gel
particles (Serodia Myco II, Fujirebio. Japan); with
Chlamydophila pneumoniae, Chlamydophila psittaci,
and Chlamydia trachomatis by microimmunofluores-
cence (Chlamydia MIF IgG, MRL Diagnostics. USA),
with Coxiella burnetii by indirect immunofluores-
cence (C. burnetii. Spot IFI. BioMe´rieux.Marcy
L’Etoile. France) and with L. pneumophila serogroups
1–6 by indirect immunofluorescence (Micro-IFA L.
pneumophila slides, Labsystems, Helsinki. Finland).Antigen detection
The presence of soluble antigens of L. pneumophila
serogroup 1 in urine was determined with anenzyme immunoassay (EIA) (Binax Legionella ur-
inary antigen EIA kit. Binax. Maine. USA), whereas
the polysaccharide capsular and the C polysacchar-
ide antigens of S. pneumoniae were determined
using the counterimmunoelectrophoresis (CIE)10
and the immunochromatographic test (ICT) (Binax
Nows S. pneumoniae urinary antigen test. Binax.
Maine, USA), respectively.
Urine samples were collected soon after admis-
sion to hospital and were frozen at 20 1C, being
immediately thawed before the test. The detection
of pneumococcal antigen was performed in NCU
and CU by selective ultrafiltration. The detection of
the L. pneumophila serogroup 1 antigen was done
in CU. The samples were tested after being stored
for 1–9 months. The antigens are thermo-resistant,
and therefore the freezing period does not inter-
fere with the detection of antigens using the
rapid tests.
Whenever possible, serial urine samples from
patients with pneumococcal pneumonia were col-
lected to establish the persistence of antigens in
urine.Etiological diagnosis
The etiological diagnosis was classified as ‘‘certain’’
or ‘‘probable’’: ‘‘certain’’ when it complied with
one of the following criteria: (1) positive blood
sample, pleural liquid or trans-thoracic needle
aspiration; (2) positive S. pneumoniae and L.
pneumophila antigen detection in urine; (3) ser-
oconversion or quadruplication of the previous
antibody titers: L. pneumophila, C. pneumoniae,
C. psittaci and C. trachomatis, M. pneumoniae and
C. burnetti; and, ‘‘probable’’ when it complied
with these criteria: (1) presence of a clinical
compatible picture; (2) absence of a certain
criterion; (3) presence of a predominant type of
microorganism after Gram staining, and/or isola-
tion of a predominant type of respiratory pathogen
in the culture and/or the detection of pneumococ-
cal antigen and type b H. influenzae in sputum
samples; (4) a unique titer in the acute phase X1/
160 against M. pneumoniae and X1/256 against L.
pneumophila.Radiological follow-up
Following discharge from hospital, the patients
were referred to the investigators at the Pulmonary
Disease Clinic of the hospital until their clinical
and radiological features had stabilized. Repeated
chest radiographies and blood samples for serolo-
gical testing were performed during follow-up.
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Table 1 Characteristics and outcome of study
cohort ðn ¼ 107Þ.
Endpoints No. (%)
Sex
Male 75 (70.1)
Female 32 (29.9)
Etiology of CAP in adults 887Statistical analysis
Data were reviewed and then entered into a
database, following which standard verification
procedures were applied. A Z-test was applied for
the comparison of two proportions. A P-value of
o0.05 was considered to be statistically signifi-
cant.Age (years)
Mean (SD) 58.58 (19.44)
Range 16–86
Smoking status
Current cigarette smokers 27 (25.2)
Ex-smokers 44 (41.1)
Never 36 (33.6)
Comorbidity
None 45 (42.1)
Pulmonary 43 (40.2)
COPD 21 (19.6)
Chronic bronchitis 12 (11.2)
Bronchiectasis 8 (7.5)
Asthma 5 (4.7)
Ischemic heart disease 9 (8.4)
Cardiac failure 3 (2.8)
Cerebrovascular disease 10 (9.3)
Parkinson disease 2 (2)
Neoplastic conditions 3 (2.8)
Immunosuppression 4 (3.7)
Diabetes mellitus 12 (11.2)
Chronic renal disease 2 (1.9)
Chronic liver disease 4 (3.7)
Prior antibiotic use 28 (26.2)
Antimicrobial treatments
Monotherapy
Amox/clav 30 (28.0)
Levofloxacin 28 (26.2)
3.gen.CS 17 (15.9)
Macrolide 1 (1)
Ciprofloxacin 1 (1)
Dual combination therapy
3.gen.CS+macrolide 20 (18.7)
Amox/clav+macrolide 2 (2)
3.gen.CS+clindamycin 2 (2)
3.gen.CS+metronidazole 1 (1)
3.gen.CS+levofloxacin 1 (1)
Imipenem+ciprofloxacin 1 (1)
Unknown 3 (2.8)
COPD ¼ chronic obstructive pulmonary disease;
Amox/clav ¼ amoxicillin clavulanate; 3.gen.CS ¼ third-
generation cephalosporin.Results
According to the aforementioned criteria, we
included in our study a total of 107 consecutive
patients diagnosed with CAP. In 84 of the patients
(78.5%), blood cultures were performed; sputum
cultures were possible in 72 patients (67.2%), and
49 patients were considered suitable for culture;
serological data for atypical pathogens (during the
acute and the convalescing phases) were obtained
from 75 patients, and the detection of polysacchar-
ide capsular antigen of S. pneumoniae in urine by
CIE was carried out in 100 patients. The pneumo-
coccal ICT test was performed in 92 NCU and 88 CU
patients out of the 107 patients with CAP. The
presence of Legionella antigen in urine was tested
in 95 patients.
Data on epidemiology, comorbidity and standard
antibiotic treatment are shown in Table 1. Out of
the 107 patients, 26.2% were taking antibiotics
prior to admission to hospital.
With the standard microbiological tests used in
our hospital we attained an etiological diagnosis
in 39 of the 107 cases (36.4%): out of these, 21
were certain and 18 were probable (Table 2). The
responsible etiological agents were the following:
S. pneumoniae in 21 cases (14 definite and 7
apparent), M. pneumoniae in 6 cases, L. pneumo-
phila in 1 case, Bacteroides sp. in 1 case, H.
influenzae in 7 cases, Pseudomonas aeruginosa in 2
cases, and Moraxella catarrhalis in 1 case.
We obtained urine samples from 92 patients
(86%) (92/107). The S. pneumoniae urinary antigen
tests by ICT were positive in 15/92 (16.3%)
of patients with pneumonia using NCU and in 29/
88 (32.9%) of those using CU (z, p) (2.63; 0.043).
The S. pneumoniae antigen was detected in the
urine of 8/14 NCU samples and in 10/13 of CU
samples from patients with pneumococcal pneu-
monia. The S. pneumoniae antigen tested by ICT
was detected in the urine of 2/6 patients with NCU
and 4/6 with CU with positive sputum cultures for
S. pneumoniae. In the pneumonias caused by other
pathogens, the antigen was not detected in any of
the 14 NCU samples and only in 1/12 CU samples. Apositive case for CAP by P. aeruginosa (probable
diagnosis) was detected in one patient with COPD.
In pneumonias with no other etiological diagnoses,
ICT was positive in 5/58 NCU samples and in 14/57
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Table 2 Comparison of the standard methods of diagnosis and the rapid urinary antigen tests in patients with
CAP.
Etiological agent Total CAP
ðn ¼ 107Þ
Conventional microbiological methods Rapid antigen test in
CU
Respiratory
samples
culture
Blood
culture
Pn urinary
antigen by
CIE
Serology Pn Legionella
S. pneumoniae
Certain 14 4 5 10 — 10 0
Probable 7 7 0 0 — 4 0
L. pneumophila 1 0 — — 1 0 0
M. pneumoniae 6 0 — — 6 0 0
H. influenzae 7 7 0 — — 0 0
P. aeruginosa 2 2 0 — — 1 0
Bacteroides spp. 1 1 0 — — 0 0
M. catarrhalis 1 1 0 — — 0 0
Unknown 68 0 0 0 0 14 5
Pn ¼ Pneumococcal.
Table 3 Results of the detection of pneumococcal antigen in urine.
Pneumococcal
pneumonia
Probable
pneumococcal
pneumonia
Pneumonia by
other etiologies
Pneumonias
without
etiological
diagnosis
ICT pneumococci NCU 8/14 (57.14%) 2/6 (33.33%) 0/14 5/58
CU 10/13 (76.92%) 4/6 (66.66%) 1/12 14/57
F. Andreo et al.888CU samples (Table 3). The positive and negative
predictive values of pneumococcal antigen detec-
tion by ICT using CU samples were 90% and 80.5%,
respectively.
In order to assess the reproducibility of the tests
all samples were tested twice, being the ICT
read by two different members of the research
team. In all cases the result was the same and
total concordance was obtained in the reading of
the tests.
Urine samples were collected at an average of
less than 1 day after admission. In 5 of the patients
in whom urine pneumococcal antigen was detected
by ICT, a second urine test was performed a month
later, and a third test 2 months later. After 1
month, the antigen was detected in 5 CU samples
and in one NCU sample. After 2 months, the antigen
remained in only the 5 CU samples.
On the one hand, antigen detection for L.
pneumophila was positive in 5 cases, compromising
the only diagnostic test in those cases. On the other
hand, the antigen was not detected in one case
that had been confirmed serologically. The number
of diagnoses increased from 39/107 (36.4%) to 44/107 (41.1%), which implied a 4.7% increase in the
total microbiological diagnosis.
The pneumococcal antigen was detected by ICT
in 15 NCU samples and in 29 CU samples; this test
was the only direct diagnostic test in 14 cases. The
inclusion of ICT for pneumococcal detection in-
creased the number of diagnosis from 36.4% to
49.5%; this was equivalent to an increase of 13.1%.
The use of new techniques for the detection of
antigens accounted for 32.7% (19/58) of all etiolo-
gical diagnoses. If we consider CIE, the antigen
detection techniques covered 43.1% of the diag-
noses, thus representing 83.3% of the diagnoses in
Legionella and 54.3% in pneumococcal pneumonia.
The inclusion of the new antigen detection techni-
ques increased the percentage of diagnoses to 54.2%
(58/107) (Fig. 1), thus representing a total increase
of 17.8% (z, p) (2.72; 0.034).Discussion
In our study, S. pneumoniae was the main respon-
sible for all the CAP diagnosed by standard tests
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Figure 1 Increase of the etiological diagnostic when
rapid urinary antigen tests for S. pneumoniae and L.
pneumophila are used.
Etiology of CAP in adults 889(21/107–19.6%) and of 21/39 (53.8%) of associated
etiology. L. pneumophila was also detected in 1
case by standard tests. These two possible diag-
nostic microorganisms by rapid techniques for
antigen detection in urine samples represented
56.4% of those with etiological diagnosis and 20.6%
of all cases studied.
In a previous study,8 the detection of pneumo-
coccal antigen in urine by ICT in adults with
pneumococcal pneumonia showed an excellent
sensitivity (82.1%) in bacteremic pneumonias and
in non-bacteremic cases (78.3%), with an out-
standing specificity (97.2%). Several studies have
confirmed these results.9,11,12 Burel et al.12 found a
sensitivity of 82% and a crude specificity of 77%,
with 13 positive results in patients with no
etiological diagnosis. In a recent study,9 the ICT
diagnosis for the detection of the S. pneumoniae
antigen in urine samples from patients diagnosed
with CAP was studied. The pneumococcal antigen
was found in 100% of the patients diagnosed with
definitive pneumococcal pneumonia, obtaining 43
positive results using CU in 171 patients affected of
pneumonia caused by an unidentified pathogen.
Therefore, ICT increased the number of diagnosis to
9.2%.
The results of our study show that using new
techniques for detecting S. pneumoniae and L.
pneumophila antigens in urine increases the num-
ber of diagnoses: from 36.4% to 41.1% when using
NCU samples and to 49.5% when using CU samples
to detect the pneumococcal antigen. The inclusion
of Legionella EIA using CU increases the number of
diagnoses to 54.2%.
Therefore, if we include the diagnoses obtained
with the antigen detection tests evaluated in our
study, S. pneumoniae was responsible for 32.7%(35/107) of total CAP and for 60.3% of associated
etiology. L. pneumophila was also a very frequent
pathogen (5.6%), and in general both microorgan-
isms assessed using antigen detection techniques
were the cause of 69% of etiological diagnoses.
As regards the correlation between isolation of S.
pneumoniae in blood culture and ICT antigen
detection, Murdoch et al.11 detected pneumococ-
cal antigen in the urine of 16 out of 20 patients with
blood cultures positive for S. pneumoniae. In
addition, Marcos et al.9 detected it in 23 out of
28 cases using NCU samples, recovering the 5
remaining cases when CU samples were used. In
contrast, in our experience ICTwas only positive in
2 of the 5 positive blood cultures for pneumococci.
However, CIE was positive in 10 cases and ICT was
positive in 7 cases using NCU and in 9 cases using
CU. These results are consistent with the idea that
the antigen present in urine is not solely originated
from the microorganism in the bloodstream,13 but
corresponds to antigen released from the lungs.
Only one patient with CAP and an etiological
diagnosis of probability for other microorganism was
positive in CU samples. The sample corresponded to
a patient with serious COPD, in whom a sputum
sample of P. aeruginosa was isolated; clinical and
radiological resolution was achieved after beta-
lactamic treatment. On the one hand, we must not
forget that the microorganism isolated in sputum
may represent colonization. On the other hand,
according to our experience with COPD patients
without a clear clinical and radiological diagnosis of
pneumonia, a positive result with ICT should be
interpreted with caution, because in COPD exacer-
bation by pneumococcal bronchial infection the
detection of pneumococcal antigen may be positive
in a high percentage of CU samples.14
Regarding the possible interference of previous
antibiotic treatments with the detection of pneu-
mococcal antigen in the urine, a second determina-
tion was done in 6 patients with pneumococcal
pneumonia and a positive ICT result at the time of
admission. This second determination was con-
ducted between 4 and 10 days after the diagnosis,
and at the beginning of the treatment with
antibiotics. The second result was also positive in
all 6 cases. Although the number of cases is very
small, it seems reasonable to state that treatment
with antibiotics does not interfere with the positive
results of the technique.
On the other hand, there are situations in which
obtaining large volumes of urine is not possible, like
patients with acute or chronic kidney failure. In our
study, the number of patients with renal failure was
small. However, no influence on the sensitivity of
the test has been detected.
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nasopharynx in adults does not seem to affect the
specificity of the test,8,9,11 it is not useful for
detecting pneumococcal pneumonia in young chil-
dren. In several evaluations performed with pedia-
tric patients,15–17 it was found that children with
nasopharyngeal carriage of S. pneumoniae showed
high rates of positive test results.
The detection techniques for Legionella soluble
antigens in urine have proven extremely useful for
a quick diagnosis of legionelosis.7 Currently, three
EIA techniques are available, all of them with an
excellent specificity and a great sensitivity. The
sensitivity using CU samples is similar in all three
EIA tests, therefore underlying the high sensitivity
of Bartel’s EIA using NCU.18
The clear advantages for the detection of
pneumococcal and Legionella antigens in direct
urine samples using new detection methods are:
easy to use; results from 15min to 3–4 h (if urine
has previously been concentrated) after performing
the technique; and, unlike most standard micro-
biological tests, it may be useful to direct the
initial antibiotic treatment.
We assess the increase in the diagnostic yield in
the detection of the S. pneumoniae antigen by ICT
after using all the standard techniques, including
the detection of the capsular polysaccharide by CIE
and we have added new data about the increase of
diagnosis using CU in the pneumococcal urinary
antigen detection. In addition we have described
that in CU the pneumococcal antigen may be
detected for more than 2 months after a pneumo-
nia episode.
Besides improving the epidemiological knowl-
edge of the CAP etiologic spectrum, its determina-
tion at the time of diagnosing pneumonia may
adjust the initial antibiotic treatment to the
etiology, reducing the range of administered anti-
biotics and, therefore, decreasing both treatment
costs and the development of resistance to anti-
biotics. Oosterheert et al.19 formulated an algo-
rithm to calculate the costs associated with the
diagnosis and treatment of CAP, to study if rapid
pneumococcal diagnostic testing lowers costs. The
conclusion was that cost savings depend on the
differences in the prices of the different antibiotics
chosen, and the proportion of available and
positive samples.
Prospective studies in which the initial treatment
should be oriented towards the etiology depending
on the results of urine antigens, as opposed to the
standard empirical treatment with antibiotics, may
be extremely helpful to determine the role played
by these antigens in clinical and therapeutical
decisions.References
1. Luna CM, Famiglietti A, Absi R, et al. Community-acquired
pneumonia: etiology, epidemiology and outcome at a
teaching hospital in Argentina. Chest 2000;118:1344–54.
2. Bates JH, Campbell GD, Barron AL, et al. Microbial etiology
of acute pneumonia in hospitalised patients. Chest
1992;101:1005–12.
3. Ruiz M, Ewing S, Marcos MA, et al. Etiology of com-
munity-acquired pneumonia: impact of age, comorbi-
dity, and severity. Am J Respir Crit Care Med 1999;160:
397–405.
4. Bartlett JG, Mundy LM. Current concepts: community-
acquired pneumonia. N Engl J Med 1995;333:1618–24.
5. Vergis EN, Yu VL. New directions for future studies of
community-acquired pneumonia: optimising impact on
patient care. Eur J Clin Microbiol Infect Dis 1999;18:847–51.
6. Ruiz-Gonza´lez A, Falguera M, Bogues A, et al. Is Strepto-
coccus pneumoniae the leading cause of pneumonia of
unknown etiology? A microbiologic study of lung aspirates in
consecutive patients with community-acquired pneumonia.
Am J Med 1999;106:385–90.
7. Domı´nguez JA, Manterola JM, Blavia R, et al. Detection of
Legionella pneumophila serogroup 1 antigen in nonconcen-
trated urine and urine concentrated by selective ultrafiltra-
tion. J Clin Microbiol 1996;34:2334–6.
8. Domı´nguez J, Galı´ N, Matas L, et al. Detection of
Streptococcus pneumoniae antigen by a rapid immuno-
chromatographic assay in urine samples. Chest 2001;119:
243–9.
9. Marcos MA, Jime´nez de Anta MT, de la Bellacasa JP, et al.
Rapid urinary antigen test for diagnosis of pneumococcal
community-acquired pneumonia in adults. Eur Respir
J 2003;21:1–6.
10. Coonrod JD, Rytel MW. Detection of type-specific pneumo-
coccal antigens by counterimmunoelectrophoresis. I. Meth-
odology and immunologic properties of pneumococcal
antigens. J Lab Clin Med 1973;81:770–7.
11. Murdoch DR, Laing RT, Mills GD, et al. Evaluation of a rapid
immunochromatographic test for detection of Streptococcus
pneumoniae antigen in urine samples from adults with
community-acquired pneumonia. J Clin Microbiol 2001;39:
3495–8.
12. Burel E, Dufour P, Gauduchon V, et al. Evaluation of a rapid
immunochromatographic assay for detection of Streptococ-
cus pneumoniae antigen in urine samples. Eur J Clin
Microbiol Infect Dis 2001;20:840–1.
13. Coonrod JD, Drennan DP. Pneumococcal pneumonia: capsu-
lar polysaccharide antigenemia and antibody responses. Ann
Intern Med 1976;84:254–60.
14. Ruiz J, Andreo F, Domı´nguez J, et al. Pneumococcal
bronchial infection versus colonization in COPD: differences
in urine antigens. Eur Respir J 2002;20(Suppl 38):544S
[abstract].
15. Domı´nguez J, Blanco S, Rodrigo C, et al. Utility of urinary
antigen detection by an immunochromatographic test in the
diagnosis of pneumococcal pneumonia in children. J Clin
Microbiol 2003;41:2161–3.
16. Dowell SF, Garman RL, Liu G, et al. Evaluation of Binax NOW,
an assay for detection of pneumococcal antigen in urine
samples, performed among paediatric patients. Clin Infect
Dis 2001;32:824–5.
17. Hamer HD, Egas J, Estrella B, et al. Assessment of the Binax
NOW Streptococcus pneumoniae urinary antigen test in
children with nasopharyngeal pneumococcal carriage. Clin
Infect Dis 2002;34:1025–8.
ARTICLE IN PRESS
Etiology of CAP in adults 89118. Domı´nguez J, Galı´ N, Blanco S, et al. Assessment of a new
test to detect Legionella urinary antigen for the diagnosis of
Legionnaire’s disease. Diagn Microbiol Infect Dis 2001;41:
199–203.19. Oosterhhert JJ, Bonten MJ, Buskens E, et al. Algorithm to
determine cost savings of targeting antimicrobial therapy
based on results of rapid diagnostic testing. J Clin Microbiol
2003;41:4708–13.
